The reverse metabolic syndrome in the elderly: Is it a “catabolic” syndrome?

  • Francesco Curcio
  • Giuseppe Sasso
  • Ilaria Liguori
  • Gaetana Ferro
  • Gennaro Russo
  • Michele Cellurale
  • David Della-Morte
  • Gaetano Gargiulo
  • Gianluca Testa
  • Francesco Cacciatore
  • Domenico Bonaduce
  • Pasquale Abete
Review

Abstract

Traditional risk factors of cardiovascular death in the general population, including body mass index (BMI), serum cholesterol, and blood pressure are also found to relate to outcomes in the geriatric population, but in a differing direction. A higher body mass index, hypercholesterolemia and hypertension are not harmful but even permit better survival at advancing age. This phenomenon is called “reverse epidemiology” or “risk factor paradox” and is also detected in a variety of chronic disease states such as chronic heart failure. Accordingly, a low BMI, blood pressure and cholesterol values are associated with a worse prognosis. Several possible causes are hypothesized to explain this elderly paradox, but this phenomenon remains controversial and its underlying reasons are poorly understood. The aim of this review is to recognize the factors behind this intriguing phenomenon and analyse the consequences that it can bring in the management of the cardiovascular therapy in elderly patient. Finally, a new phenotype identified as “catabolic syndrome” has been postulated.

Keywords

Body mass index Blood pressure Cholesterol Reverse epidemiology Catabolic syndrome 

References

  1. 1.
    Teo KK, Dokainish H (2017) The emerging epidemic of cardiovascular risk factors and atherosclerotic disease in developing countries. Can J Cardiol 33:358–365CrossRefPubMedGoogle Scholar
  2. 2.
    Garber AJ (2002) Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obes Metab 4:S5–S12CrossRefPubMedGoogle Scholar
  3. 3.
    Casiglia E, Palatini P (1998) Cardiovascular risk factors in the elderly. J Hum Hypertens 12:575–581CrossRefPubMedGoogle Scholar
  4. 4.
    Kannel WB (2002) Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 11:101–107CrossRefPubMedGoogle Scholar
  5. 5.
    Ahmadi SF, Streja E, Zahmatkesh G et al (2015) Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population. J Am Med Dir Assoc 16:933–939CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kalantar-Zadeh K, Horwich TB, Oreopoulos A et al (2007) Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 10:433–442CrossRefPubMedGoogle Scholar
  7. 7.
    Charnigo R, Guglin M (2017) Obesity paradox in heart failure: statistical artifact, or impetus to rethink clinical practice? Heart Fail Rev 22:13–23CrossRefPubMedGoogle Scholar
  8. 8.
    Kalantar-Zadeh K, Rhee CM, Amin AN (2014) To legitimize the contentious obesity paradox. Mayo Clin Proc 89:1033–1035CrossRefPubMedGoogle Scholar
  9. 9.
    Park J, Ahmadi SF, Streja E et al (2014) Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis 56:415–425CrossRefPubMedGoogle Scholar
  10. 10.
    Vasan RS, Larson MG, Leip EP et al (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345:1291–1297CrossRefPubMedGoogle Scholar
  11. 11.
    Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet 360:1903–1913CrossRefGoogle Scholar
  12. 12.
    Mørkedal B, Romundstad PR, Vatten L (2011) Mortality from ischaemic heart disease: age-specific effects of blood pressure stratified by body-mass index: the HUNT cohort study in Norway. J Epidemiol Community Health 65:814–819CrossRefPubMedGoogle Scholar
  13. 13.
    Oates DJ, Berlowitz DR, Glickman ME et al (2007) Blood pressure and survival in the oldest old. J Am Geriatr Soc 55:383–388CrossRefPubMedGoogle Scholar
  14. 14.
    Gutiérrez-Misis A, Sánchez-Santos MT, Banegas JR et al. (2013) Association between blood pressure and mortality in a Spanish cohort of persons aged 65 years or over: a dynamic model. Rev Esp Cardiol (Engl edn) 66:464–471CrossRefGoogle Scholar
  15. 15.
    Cacciatore F, Abete P, de Santis D et al (2005) Mortality and blood pressure in elderly people with and without cognitive impairment. Gerontology 51:53–61CrossRefPubMedGoogle Scholar
  16. 16.
    Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM et al (2010) Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens 28:1366–1372CrossRefPubMedGoogle Scholar
  17. 17.
    Schall P, Wehling M (2011) Treatment of arterial hypertension in the very elderly: a meta-analysis of clinical trials. Arzneimittelforschung 61:221–228CrossRefPubMedGoogle Scholar
  18. 18.
    Williamson JD, Supiano MA, Applegate WB et al (2016) SPRINT research group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 315:2673–2682CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Benetos A, Bulpitt CJ, Petrovic M et al (2016) An expert opinion from the European society of hypertension–European union geriatric medicine society working group on the management of hypertension in very old, frail subjects. Hypertension 67:820–825CrossRefPubMedGoogle Scholar
  20. 20.
    Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4:487–499CrossRefPubMedGoogle Scholar
  21. 21.
    Kalback W, Esh C, Castaño EM et al (2004) Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer’s disease. Neurol Res 26:525–539CrossRefPubMedGoogle Scholar
  22. 22.
    Scuteri A, Tesauro M, Guglini L et al (2013) Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss. Int J Cardiol 169:371–377CrossRefPubMedGoogle Scholar
  23. 23.
    Scuteri A, Morrell CH, Orrù M et al (2014) Longitudinal perspective on the conundrum of central arterial stiffness, blood pressure, and aging. Hypertension 64:1219–1227CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Rotella CM, Dicembrini I (2015) Measurement of body composition as a surrogate evaluation of energy balance in obese patients. World J Methodol 5:1–9CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Berrington de Gonzalez A, Hartge P, Cerhan JR et al (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363:2211–2219CrossRefPubMedGoogle Scholar
  26. 26.
    Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P et al (2009) Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. The Lancet 373:1083–1096CrossRefGoogle Scholar
  27. 27.
    Mattila K, Haavisto M, Rajala S (1986) Body mass index and mortality in the elderly. BMJ (Res Clin) 292:867–868CrossRefGoogle Scholar
  28. 28.
    Cornoni-Huntley JC, Harris TB, Everett DF et al (1991) An overview of body weight of older persons, including the impact on mortality. The national health and nutrition examination survey I—epidemiologic follow-up study. J Clin Epidemiol 44:743–753CrossRefPubMedGoogle Scholar
  29. 29.
    Stevens J, Cai J, Pamuk ER et al (1998) The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1–7CrossRefPubMedGoogle Scholar
  30. 30.
    Wang Z (2015) Age-dependent decline of association between obesity and mortality: a systematic review and meta-analysis. Obes Res Clin Pract 9:1–11CrossRefPubMedGoogle Scholar
  31. 31.
    Al Snih S, Ottenbacher KJ, Markides KS et al (2007) The effect of obesity on disabilitys mortality in older Americans. Arch Intern Med 167:774–780CrossRefPubMedGoogle Scholar
  32. 32.
    Flicker L, McCaul KA, Hankey GJ et al (2010) Body mass index and survival in men and women aged 70 to 75. J Am Geriatr Soc 58:234–241CrossRefPubMedGoogle Scholar
  33. 33.
    Holme I, Tonstad S (2015) Survival in elderly men in relation to midlife and current BMI. Age Ageing 44:434–439CrossRefPubMedGoogle Scholar
  34. 34.
    Batsis JA, Singh S, Lopez-Jimenez F (2014) Anthropometric measurements and survival in older Americans: results from the third national health and nutrition examination survey. J Nutr Health Aging 18:123–130CrossRefPubMedGoogle Scholar
  35. 35.
    Rolland Y, Gallini A, Cristini C et al (2014) Body-composition predictors of mortality in women aged > 75 y: data from a large population-based cohort study with a 17-y follow-up. Am J Clin Nutr 100:1352–1360CrossRefPubMedGoogle Scholar
  36. 36.
    Testa G, Cacciatore F, Galizia G et al (2010) Waist circumference but not body mass index predicts long-term mortality in elderly subjects with chronic heart failure. J Am Geriatr Soc 58:1433–1440CrossRefPubMedGoogle Scholar
  37. 37.
    Bales CW, Buhr G (2008) Is obesity bad for older persons? A systematic review of the prosand cons of weight reduction in later life. J Am Med Dir Assoc 9:302–312CrossRefPubMedGoogle Scholar
  38. 38.
    Klag MJ, Ford DE, Mead LA et al (1993) Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328:313–318CrossRefPubMedGoogle Scholar
  39. 39.
    Kronmal RA, Cain KC, Ye Z et al (1993) Total serum cholesterol levels and mortality risk as a function of age, a report based on the Framingham data. Arch Intern Med 153:1065–1073CrossRefPubMedGoogle Scholar
  40. 40.
    Schatz IJ, Masaki K, Yano Ket al (2001) Cholesterol and all-cause mortality in elderly people from the Honolulu heart program: a cohort study. The Lancet 358:351–355CrossRefGoogle Scholar
  41. 41.
    Tikhonoff V, Casiglia E, Mazza A et al (2005) Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 53:2159–2164CrossRefPubMedGoogle Scholar
  42. 42.
    Volpato S, Leveille SG, Corti MC et al (2001) The value of serum albumin and high density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 49:1142–1147CrossRefPubMedGoogle Scholar
  43. 43.
    Weverling-Rijnsburger AW, Jonkers IJ, van Exel E et al (2003) High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 163:1549–1554CrossRefPubMedGoogle Scholar
  44. 44.
    Petersen LK, Christensen K, Kragstrup J (2010) Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80 year olds. Age Ageing 39:674–680CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Savarese G, Gotto AM, Paolillo S et al (2013) Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol 62:2090–2099CrossRefPubMedGoogle Scholar
  46. 46.
    Stone NJ, Robinson J, Lichtenstein AH et al (2013) ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation 129:S1–S72CrossRefPubMedGoogle Scholar
  47. 47.
    Authors/task force members, Catapano AL, Graham I, De Backer G et al (2016) ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 253: 281–344CrossRefGoogle Scholar
  48. 48.
    Scuteri A, Najjar SS, Morrell CH et al (2005) Cardiovascular Health Study. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 28:882–887CrossRefPubMedGoogle Scholar
  49. 49.
    Scuteri A, Najjar SS, Orru’ M et al (2010) The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study. Eur Heart J 31:602–613CrossRefPubMedGoogle Scholar
  50. 50.
    Scuteri A, Orru M, Morrell C et al (2011) Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis 215:459–464CrossRefPubMedGoogle Scholar
  51. 51.
    Testa G, Cacciatore F, Galizia G et al (2009) Charlson comorbidity index does not predict long-term mortality in elderly subjects with chronic heart failure. Age Ageing 38:734–740CrossRefPubMedGoogle Scholar
  52. 52.
    Shimura M, Gosho M, Hirakawa A (2017) Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data. Stat Med 36:2067–2080CrossRefPubMedGoogle Scholar
  53. 53.
    Vischer UM, Safar ME, Safar H et al (2009) Cardiometabolic determinants of mortality in a geriatric population: is there a “reverse metabolic syndrome”? Diabetes Metab 35:108–114CrossRefPubMedGoogle Scholar
  54. 54.
    Herrington W, Staplin N, Judge PK et al (2017) SHARP collaborative group, evidence for reverse causality in the association between blood pressure and cardiovascular risk in patients with chronic kidney disease. Hypertension 69:314–322CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Galizia G, Cacciatore F, Testa G et al (2011) Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin Exp Res 23:118–125CrossRefPubMedGoogle Scholar
  56. 56.
    Cacciatore F, Testa G, Galizia G et al (2013) Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta Diabetol 50:251–260CrossRefPubMedGoogle Scholar
  57. 57.
    Jabir NR, Tabrez S (2016) Cardiovascular disease management through restrained inflammatory responses. Curr Pharm Des 22:940–946CrossRefPubMedGoogle Scholar
  58. 58.
    Kalantar-Zadeh K, Kopple JD (2006) Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 151:57–69CrossRefPubMedGoogle Scholar
  59. 59.
    Mohamed-Ali V, Goodrick S, Bulmer K et al (1999) Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277:E971–E975PubMedGoogle Scholar
  60. 60.
    van Greevenbroek MM, Schalkwijk CG, Stehouwer CD (2016) Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advances. Faculty Rev-2515 Review 13Google Scholar
  61. 61.
    Rosenthal MD, Moore FA (2015) Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): new phenotype of multiple organ failure. J Adv Nutr Hum Metab 1:e784PubMedPubMedCentralGoogle Scholar
  62. 62.
    Lavie CJ, De Schutter A, Alpert MA, Mehra MR, Milani RV, Ventura HO (2014) Obesity paradox, cachexia, frailty, and heart failure. Heart Fail Clin 10:319–326CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Francesco Curcio
    • 1
  • Giuseppe Sasso
    • 1
  • Ilaria Liguori
    • 1
  • Gaetana Ferro
    • 2
  • Gennaro Russo
    • 1
  • Michele Cellurale
    • 1
  • David Della-Morte
    • 3
    • 4
  • Gaetano Gargiulo
    • 5
  • Gianluca Testa
    • 1
    • 6
  • Francesco Cacciatore
    • 1
    • 7
  • Domenico Bonaduce
    • 1
  • Pasquale Abete
    • 1
  1. 1.Department of Translational Medical SciencesUniversity of Naples “Federico II”NaplesItaly
  2. 2.Department of EmergencyA.O.R.N. Antonio CardarelliNaplesItaly
  3. 3.Department of Systems MedicineUniversity of Rome Tor VergataRomeItaly
  4. 4.San Raffaele Roma Open UniversityRomeItaly
  5. 5.Division of Internal MedicineAOU San Giovanni di Dio e Ruggi di AragonaSalernoItaly
  6. 6.Department of Medicine and Health SciencesUniversity of MoliseCampobassoItaly
  7. 7.Heart Transplantation Unit, Monaldi HospitalAzienda Ospedaliera dei ColliNaplesItaly

Personalised recommendations